The flu vaccine is just 17% effective against the current virus; Indiana dropped 25,000 people from its Medicaid program for not paying premiums; the CDC is cutting back on efforts to prevent infectious disease outbreaks in other countries as funding runs out.
The current flu season has been particularly harsh, with 41.9 hospitalizations per 100,000 people and approximately 40 pediatric deaths. New research in Canada has found that the vaccine has just been 17% effective at preventing infection, reported STAT. Last year, the vaccine was estimated to be 37% effective in Canada. The CDC has yet to analyze its midseason flu vaccine effectiveness data and expects to publish its analysis in a few weeks. The findings confirm that people who have been vaccinated are still contracting the flu.
In Indiana, the Medicaid program was expanded under the Affordable Care Act with some changes approved by the Obama administration, namely monthly fees and lockout provisions. According to Kaiser Health News, those provisions led to 25,000 adults being disenrolled from Medicaid between 2015 and October 2017. Half of those dropped from the program had found another source of coverage, mostly through a job. Another 46,000 adults were not accepted into the program during 2016 and 2017 because they did not pay their initial premiums.
With money running out, the United States is going to scale back its involvement in preventing infectious disease epidemics in 39 of 49 countries. The Washington Post reported that the CDC had been given $600 million by Congress in 2014 to help countries combat infectious disease outbreaks, but the money will run out in September 2019. The agency has been notifying officials abroad about plans to downsize its epidemic prevention activities under the assumption that the Trump administration will not budget additional resources.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More